Antimitotic Agents: all 5,052 studies that test it
Page 27 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Risk Adapted Therapy in Diffuse Large B Cell LymphomaStatus unknownNCT03188198Phase 2
- Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian CancerStatus unknownNCT03188159Phase 2
- A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingNCT03178552Phase 2/3
- Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLCCompletedNCT03177291Phase 1
- Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT03177174Not applicable
- QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyWithdrawnNCT03175666Phase 1/2
- QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLWithdrawnNCT03169790Phase 1/2
- QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCWithdrawnNCT03169777Phase 1/2
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03169764Phase 1/2
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
- A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast CancerActive, not recruitingNCT03168880Phase 3
- QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03167177Phase 1/2
- QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyWithdrawnNCT03167164Phase 1/2
- PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerCompletedNCT03166085Phase 1
- Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersCompletedNCT03162510Phase 1
- Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell LymphomasCompletedNCT03161054Phase 2
- FIL Study on ABVD DD-DI as Upfront Therapy in HL.CompletedNCT03159897Phase 3
- COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial InfarctionCompletedNCT03156816Phase 2
- The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric CancerStatus unknownNCT03154983Phase 2
- Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast CancerStatus unknownNCT03147963Phase 2
- Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)WithdrawnNCT03143491Phase 2
- Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric CancerStatus unknownNCT03137004Phase 2
- The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With GoutCompletedNCT03131583Phase 1
- QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic CancerWithdrawnNCT03127124Phase 1/2
- Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian CancerCompletedNCT03126812Phase 1/2
- Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast CancerActive, not recruitingNCT03125928Phase 2
- Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14Status unknownNCT03119857Phase 3
- A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the PenisCompletedNCT03114254Phase 2
- Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung CancerCompletedNCT03092986Phase 4
- MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.CompletedNCT03089645Phase 1
- Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid CancerActive, not recruitingNCT03085056Early Phase 1
- Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
- A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.Status unknownNCT03076957Phase 1/2
- A Study Evaluating MM-310 in Patients With Solid TumorsStatus unknownNCT03076372Phase 1
- A Clinical Trial of Apatinib Plus Docetaxel in Locally Advanced or Metastatic Gastric or GEJ AdenocarcinomaStatus unknownNCT03071042Phase 1
- Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryActive, not recruitingNCT03070886Phase 2/3
- Clarify of Predictive Risk Factors of Chemotherapy-induced Liver InjuryStatus unknownNCT03069820Phase 4
- FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerCompletedNCT03067792Phase 3
- Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate CancerTerminatedNCT03066154Phase 1
- An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic AdenocarcinomaStatus unknownNCT03061643Phase 2
- Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast CancerWithdrawnNCT03058939Phase 2
- Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial TractCompletedNCT03051373Phase 2
- Cabazitaxel in mCRPC Patients With AR-V7 Positive Circulating Tumor Cells (CTCs)Status unknownNCT03050866Phase 2
- Colchicine and Spironolactone in Patients with MI / SYNERGY Stent RegistryCompletedNCT03048825Phase 3
- Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03047265Phase 2
- mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJAStatus unknownNCT03045770Not applicable
- Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, ClarithromycinTerminatedNCT03043989Phase 1
- Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer PatientsWithdrawnNCT03032614Phase 2
- A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube CancerCompletedNCT03030287Phase 1
- A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer PatientsStatus unknownNCT03026881Phase 1
- Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03020329Phase 2
- R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCLStatus unknownNCT03018626Phase 3
- A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast CancerCompletedNCT03017404Not applicable
- Paediatric Hepatic International Tumour TrialActive, not recruitingNCT03017326Phase 3
- Effect of Low Dose ColchiciNe on the InciDence of POAFTerminatedNCT03015831Phase 3
- Fosbretabulin With Everolimus in Neuroendocrine Tumors With ProgressionTerminatedNCT03014297Phase 1
- An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing SurgeryCompletedNCT03011320Phase 1
- A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibTerminatedNCT03008512Phase 2
- Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerCompletedNCT03007992Phase 2
- PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03006614Phase 3
- PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMACompletedNCT03006432Phase 3
- Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque TestCompletedNCT03004339Phase 1
- Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 TrialCompletedNCT03003546Phase 1
- To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Solid TumorsCompletedNCT03002493Phase 1
- A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast CancerSuspendedNCT03002103Phase 3
- Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC PatientsStatus unknownNCT03002064Phase 3
- Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT02997332Phase 1
- Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)Status unknownNCT02996214Phase 4
- Mechanistic Effects of Colchicine in Patients With Myocardial InfarctionWithdrawnNCT02995512Phase 4
- Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple MyelomaWithdrawnNCT02985333Phase 2
- Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral TongueStatus unknownNCT02985255Phase 2
- Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung CancerTerminatedNCT02985203Phase 2
- Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBCTerminatedNCT02982395Phase 3
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell CarcinomaCompletedNCT02976909Phase 2
- Ph1b Study of Oraxol in Comb. w. Ramucirumab in Patients w. Gastric, Gastro-esophageal, or Esophageal CancersStatus unknownNCT02970539Phase 1
- Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT02969473Phase 2
- Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaCompletedNCT02964455Phase 1
- A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. MalignanciesStatus unknownNCT02963168Phase 1
- Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a DocetaxelCompletedNCT02961257Phase 3
- Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyCompletedNCT02948075Phase 2
- S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast CancerStatus unknownNCT02947061Phase 2
- Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine CarcinomaStatus unknownNCT02943798Phase 2
- Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction CancersStatus unknownNCT02934464Phase 3
- Multicentric Randomised Trial for Resectable Gastric CancerActive, not recruitingNCT02931890Phase 2
- Effect of Colchicine on Range of Motion After Manipulation Under Anesthesia for the Stiff Total Knee ReplacementSuspendedNCT02926248Phase 4
- Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced MalignancyCompletedNCT02925000Phase 1/2
- Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity CancerCompletedNCT02923258Phase 2/3
- Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.CompletedNCT02922777Phase 1
- A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerCompletedNCT02922764Phase 1
- Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland TumorsCompletedNCT02921984Phase 1
- Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02921022Not applicable
- Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase ExpressionTerminatedNCT02919462Phase 2
- Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT02916511Phase 2
- Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPCCompletedNCT02913196Phase 1
- Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate CancerCompletedNCT02911350Phase 1
- Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic StrokeCompletedNCT02898610Phase 3
- A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric CancerCompletedNCT02890511Phase 1/2
- An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation StudyStatus unknownNCT02884479Phase 1/2
- Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell CarcinomaCompletedNCT02881125Phase 1